-
Ingevity Corp (NGVT) PT Raised to $70 at BMO Capital
-
Ingevity announces executive leadership changes effective 2025 and 2026
-
Ingevity (NGVT) Tops Q3 EPS by 13c, provides guidance
-
Ingevity appoints Ruth Castillo as president of Performance Materials
-
U.S. chemical stocks: Q3 earnings preview
-
Ingevity Corp (NGVT) PT Raised to $68 at BMO Capital
-
Ingevity Corp (NGVT) PT Raised to $62 at BMO Capital
-
Ingevity (NGVT) Tops Q2 EPS by 23c, provides guidance
-
Ingevity (NGVT) announces departure of Performance Materials segment president, Ed Woodcock
-
Ingevity Corp (NGVT) PT Lowered to $47 at Jefferies
-
Ingevity (NGVT) Tops Q1 EPS by 25c, Misses on Revenue; Offers FY25 Revenue Guidance
-
Ingevity (NGVT) Appoints David H. Li as president and CEO
-
BMO Capital Upgrades Ingevity Corp (NGVT) to Outperform
-
Ingevity (NGVT) Highlights Significant Momentum on Actions Underway to Drive Improved Performance and Value Creation
-
BMO Capital: 'Ingevity Corp (NGVT) Starting to See the Benefits of Past Heavily Lifting'; PT Raised
-
Ingevity (NGVT) Tops Q4 EPS by 70c, provides guidance
-
Ingevity (NGVT) to explore strategic alternatives for Performance Chemicals Industrial Specialties product line and North Charleston CTO refinery; releases preliminary 2024 financial results
-
Ingevity (NGVT) Appoints Kevin Willis to its Board
-
Ingevity Corp (NGVT) PT Raised to $47 at BMO Capital
-
Ingevity (NGVT) Tops Q3 EPS by 22c, provides guidance
-
Jefferies Reiterates Buy Rating on Ingevity (NGVT) following CEO departure
-
Ingevity (NGVT) announces CEO transition
-
Ingevity Corp (NGVT) PT Lowered to $42 at BMO Capital
-
Ingevity (NGVT) Misses Q2 EPS by 4c, raises guidance
-
Ingevity Corp (NGVT) PT Lowered to $45 at BMO Capital
-
Ingevity (NGVT) and Georgia Pacific enter into termination agreement and release to terminate CTO Supply Agreement

